Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Active, not recruiting · NCT06489041 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating Microarray Pharmacogenetic Testing in Cancer Patients | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, cancer, digestive system disorder, digestive system neoplasm, neoplasm | Active, not recruiting | Not applicable | 2026-07-27 | NCT06489041 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atrium Health Levine Cancer Institute | 27 |
| Wake Forest University Health Sciences | 284 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Levine Cancer | Charlotte | United States | 13 |